These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36977546)

  • 21. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
    Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
    J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
    Dohadwala M; Link MS
    Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
    Groeneweg JA; Bhonsale A; James CA; te Riele AS; Dooijes D; Tichnell C; Murray B; Wiesfeld AC; Sawant AC; Kassamali B; Atsma DE; Volders PG; de Groot NM; de Boer K; Zimmerman SL; Kamel IR; van der Heijden JF; Russell SD; Jan Cramer M; Tedford RJ; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Hauer RN; Calkins H
    Circ Cardiovasc Genet; 2015 Jun; 8(3):437-46. PubMed ID: 25820315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.
    Cohen TJ; Zadeh H; Fruauff A; Klein J
    J Invasive Cardiol; 2000 Aug; 12(8):422-4. PubMed ID: 10953107
    [No Abstract]   [Full Text] [Related]  

  • 31. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential Inappropriate Subcutaneous Implantable Cardioverter-Defibrillator Shocks: Pro-Arrhythmia Followed by Failure to Rescue.
    Torres CA; Helguera ME; Pinski SL; Baez-Escudero JL
    JACC Clin Electrophysiol; 2017 Jul; 3(7):782-784. PubMed ID: 29759545
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
    Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy.
    Bosman LP; Nielsen Gerlach CL; Cadrin-Tourigny J; Orgeron G; Tichnell C; Murray B; Bourfiss M; van der Heijden JF; Yap SC; Zeppenfeld K; van den Berg MP; Wilde AAM; Asselbergs FW; Tandri H; Calkins H; van Tintelen JP; James CA; Te Riele ASJM
    Europace; 2022 Feb; 24(2):296-305. PubMed ID: 34468736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Redetection of tachycardia in severe ventricular undersensing].
    Steffel J
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):240-3. PubMed ID: 27459975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.